In retrospective exploratory research, increased tumor apelin expression and obesity were independently linked to lower pathological complete response rates in 62 early BCa patients treated with taxane and anthracycline-based neoadjuvant chemotherapy. This evidence concerns the gene APLN and obesity disorder.